Einar Sjaastad Norden
Overview
Explore the profile of Einar Sjaastad Norden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Norden E, Bendiksen B, Bergo K, Espe E, McGinley G, Hasic A, et al.
ESC Heart Fail
. 2024 Dec;
PMID: 39696842
Aims: Sacubitril/valsartan (Sac/Val) is used for treatment of heart failure. The effect of Sac/Val on regional dysfunction following myocardial infarction (MI) remains uncertain. This study aimed at understanding the effects...
2.
Norden E, Veras I, Yadav P, Loken K, Dishington H, Thorstensen C, et al.
Lab Anim
. 2023 Sep;
58(1):34-43.
PMID: 37669442
Serum corticosterone, serum buprenorphine, body weight change, consumption of food and water and behaviour-based pain assessment were measured in catheterised and non-catheterised male Wistar rats undergoing myocardial infarct (MI) surgery...
3.
Vistnes M, Erusappan P, Sasi A, Norden E, Bergo K, Romaine A, et al.
Cardiovasc Res
. 2023 May;
119(10):1915-1927.
PMID: 37216909
Aims: Heart failure is a condition with high mortality rates, and there is a lack of therapies that directly target maladaptive changes in the extracellular matrix (ECM), such as fibrosis....
4.
Norden E, Bendiksen B, Andresen H, Bergo K, Espe E, Hasic A, et al.
ESC Heart Fail
. 2021 Jan;
8(2):918-927.
PMID: 33497525
Aims: Sacubitril/valsartan (sac/val) has shown superior effect compared with blockade of the renin-angiotensin-aldosterone system in heart failure with reduced ejection fraction. We aimed to investigate effects of sac/val compared with...
5.
Harbo M, Norden E, Narula J, Sjaastad I, Espe E
Prog Cardiovasc Dis
. 2020 Jun;
63(5):552-560.
PMID: 32502560
In heart failure (HF) management, noninvasive quantification of left ventricular (LV) function is rapidly evolving. Deformation parameters, such as strain, continue to challenge the central role of ejection fraction (EF)...
6.
McGinley G, Bendiksen B, Zhang L, Aronsen J, Norden E, Sjaastad I, et al.
PLoS One
. 2019 Jul;
14(7):e0218874.
PMID: 31276508
Introduction: Tissue Phase Mapping (TPM) MRI can accurately measure regional myocardial velocities and strain. The lengthy data acquisition, however, renders TPM prone to errors due to variations in physiological parameters,...
7.
Roe A, Ruud M, Espe E, Manfra O, Longobardi S, Aronsen J, et al.
Cardiovasc Res
. 2018 Oct;
115(4):752-764.
PMID: 30351410
Aims: Regional heterogeneities in contraction contribute to heart failure with reduced ejection fraction (HFrEF). We aimed to determine whether regional changes in myocardial relaxation similarly contribute to diastolic dysfunction in...